首页>
外国专利>
Histone deacetylase inhibitor enhancement of trail-induced apoptosis
Histone deacetylase inhibitor enhancement of trail-induced apoptosis
展开▼
机译:组蛋白脱乙酰基酶抑制剂增强诱导的凋亡
展开▼
页面导航
摘要
著录项
相似文献
摘要
Due to the poor long-term clinical outcome in the adult patients with several forms of acute leukemia novel treatment strategies are needed to overcome resistance and sensitize the leukemia blasts to the extrinsic and intrinsic pathway of apoptosis. Treatment with LAQ824 and Apo-2L/TRAIL alone has been recognized to induce apoptosis of leukemia blasts but intrinsic mechanisms of resistance limit the antileukemia activity of either agent when administered alone. The inventive method overcomes the resistance to current apoptosis inducing treatments demonstrated by AML and CML-BC cells by concomitantly administering Apo-2L/TRAIL with the histone deacetylase inhibitor LAQ824.
展开▼